The Effect of Muscarinic Receptor Modulators on the Antinociception Induced by CB2 Receptor Agonist, JWH133 in Mice

被引：1
|
作者：
Alipour, M. [1 ]
Fekrmandi, F. [2 ]
Onsori, S. [1 ]
Tabrizian, P. [1 ]
Jafari, M. R. [1 ]
机构：
[1] Zanjan Univ Med Sci, Sch Med, Dept Physiol & Pharmacol, Zanjan 45147, Iran
[2] McGill Univ, Dept Med, Montreal, PQ, Canada
来源：
DRUG RESEARCH | 2016年 / 66卷 / 11期
关键词：
antinociception; JWH-133; pilocarpine; atropine; formalin test; mice;
D O I：
10.1055/s-0042-112365
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
There is no published study regarding the interaction between muscarinic receptor modulators and antinociception induced by cannabinoid receptor (CB2) agonist. The effect of pilocarpine (a muscarinic agonist) and atropine (a muscarinic antagonist) on JWH-133 (a CB2 agonist) induced analgesia in mice was studied. First the analgesic effect of JWH-133 (0.001-1mg/Kg) or pilocarpine (2.5-20mg/kg) or atropine (0.2-5mg/kg) was evaluated. Subsequently, the effect of co-administration of pilocarpine (2.5mg/kg) or atropine (5mg/kg) and JWH-133 (0.001-1mg/Kg) were studied too. JWH-133 and pilocarpine provoked antinociception in mice but atropine did not. Pilocarpine potentiated the analgesic effect of JWH-133 but atropine antagonized that. It can be concluded that JWH-133 induced antinociception is affected by muscarinic receptor modulators in mice.
引用
收藏
页码：597 / 602
页数：6
相关论文
共 50 条
  • [1] Influence of nicotinic receptor modulators on CB2 cannabinoid receptor agonist (JWH133)-induced antinociception in mice
    Jafari, Mohammad R.
    Golmohammadi, Somaye
    Ghiasvand, Fereshteh
    Zarrindast, Mohammad R.
    Djahanguiri, Bijan
    BEHAVIOURAL PHARMACOLOGY, 2007, 18 (07): : 691 - 697
  • [2] Pharmacological Properties, Therapeutic Potential and Molecular Mechanisms of JWH133, a CB2 Receptor-Selective Agonist
    Hashiesh, Hebaallah Mamdouh
    Sharma, Charu
    Goyal, Sameer N.
    Jha, Niraj Kumar
    Ojha, Shreesh
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [3] CB2 receptor agonist JWH133 activates AMPK to inhibit growth of C6 glioma cells
    Wang, Feng
    Wang, Jing
    Zhao, Tong
    Zhang, Yi
    Li, Qian
    OPEN LIFE SCIENCES, 2019, 14 (01): : 363 - 375
  • [4] Modified Alginate-Based Hydrogel as a Carrier of the CB2 Agonist JWH133 for Bone Engineering
    Zhou, Wei
    Li, Qianming
    Ma, Ruixiang
    Huang, Wei
    Zhang, Xianzuo
    Liu, Yingsheng
    Xu, Ze
    Zhang, Linlin
    Li, Meng
    Zhu, Chen
    ACS OMEGA, 2021, 6 (10): : 6861 - 6870
  • [5] Protective effect of intervention with cannabinoid type-2 receptor agonist JWH133 on pulmonary fibrosis in mice
    吴潇
    ChinaMedicalAbstracts(InternalMedicine), 2023, 40 (03) : 173 - 174
  • [6] Anti-Obesity Effect of the CB2 Receptor Agonist JWH-015 in Diet-Induced Obese Mice
    Verty, A. N. A.
    Stefanidis, A.
    McAinch, A. J.
    Hryciw, D. H.
    Oldfield, Brian
    PLOS ONE, 2015, 10 (11):
  • [7] Anti-apoptotic and Immunomodulatory Effect of CB2 Agonist, JWH133, in a Neonatal Rat Model of Hypoxic-Ischemic Encephalopathy
    Gupta, Bhavna
    Hornick, Mary G.
    Briyal, Seema
    Donovan, Ramona
    Prazad, Preetha
    Gulati, Anil
    FRONTIERS IN PEDIATRICS, 2020, 8
  • [8] Activation of cannabinoid receptor type 2 by JWH133 alleviates bleomycin-induced pulmonary fibrosis in mice
    Fu, Qiang
    Zheng, Yi
    Dong, Xin
    Wang, Li
    Jiang, Chun Guo
    ONCOTARGET, 2017, 8 (61) : 103486 - 103498
  • [9] Anticancer effects of cannabinoid type 2 receptor agonist JWH133 on Prostate Cancer cell lines
    Ozcan, Seda Sabah
    Yapar, Rehime
    Degerli, Ismail
    Elmas, Levent
    Korkmaz, Mehmet
    Cakir, Murat
    ACTA PHYSIOLOGICA, 2025, 241 : 69 - 69
  • [10] CB2 cannabinoid receptor mediation of antinociception
    Ibrahim, Mohab M.
    Rude, Megan L.
    Stagg, Nicola J.
    Mata, Heriberto P.
    Lai, Josephine
    Vanderah, Todd W.
    Porreca, Frank
    Buckley, Nancy E.
    Makriyannis, Alexandros
    Malan, T. Philip, Jr.
    PAIN, 2006, 122 (1-2) : 36 - 42
12345